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Intein-mediated protein splicing has become an essential tool in modern biotechnology. Fundamental progress in
the structure and catalytic strategies of cis- and trans-splicing inteins has led to the development of modified
inteins that promote efficient protein purification, ligation, modification and cyclization. Recent work has extended
these in vitro applications to the cell or to whole organisms. We review recent advances in intein-mediated protein
expression and modification, post-translational processing and labeling, protein regulation by conditional protein
splicing, biosensors, and expression of trans-genes.
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Protein splicing is a post-translational process by which
an intervening polypeptide, called an intein, catalyzes its
own excision from the flanking polypeptides, or exteins,
as well as ligation of the exteins (Figure 1A).
Many inteins are interrupted by homing endonuclease
domains similar to those found in mobile introns. How-
ever, the homing endonuclease domain can be deleted
from the intein without complete loss of splicing activity
and is absent in a class of inteins called mini-inteins [1].
The mechanism of splicing for canonical inteins is a
four-step process (Figure 2) [1,2]. First, the peptide bond
linking the N-extein and intein is converted to a thioe-
ster or ester via nucleophilic attack by the N-terminal
Cys or Ser of the intein (Step 1). Second, the N-extein is
transferred from the side chain of the first intein residue
to the side chain of the first C–extein residue (Cys, Ser
or Thr) by transesterification, resulting in a branched
ester intermediate (Step 2). Third, the branched ester is
resolved by Asn cyclization coupled to peptide bond
cleavage (Step 3). This leaves the ligated exteins sepa-
rated from the intein and linked by an ester bond, while
the intein has a C-terminal aminosuccinimide. Finally,
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article, unless otherwise stated.converted to the amide bond, and the C-terminal amino-
succinimide of the intein may be hydrolyzed (Step 4).
Two side reactions can occur if the splicing process is
disrupted (Figure 1 B and C). The ester or thioester
formed in Steps 1 and/or 2 may be cleaved by hydrolysis
or thiolysis, uncoupled from Asn cyclization. This
process is called N-terminal cleavage, and results in
cleavage of the N-extein from the precursor (Figure 1B).
Alternatively, Asn cyclization may occur uncoupled from
Steps 1 and 2, freeing the C-extein in a process called C-
terminal cleavage (Figure 1C).
Some inteins are expressed as two separate fragments,
either natively or by protein engineering, and facilitate
protein splicing in trans (Figure 1D). In protein trans-
splicing, or PTS, reassociation of the intein fragments is
required prior to splicing.
Both cis- and trans-splicing inteins have been engi-
neered to undergo conditional protein splicing, or CPS
(Figure 1E). CPS requires the addition of a trigger to ini-
tiate splicing of a precursor fusion protein. Such triggers
include light, changes in pH or temperature, change in
redox state, or the addition of a small molecule [2-6].
For CPS of trans-splicing inteins, split dimerization do-
mains have been fused to the intein fragments to make
reassociation conditional on addition of a small molecule
or on the affinity of the domains [2-6].
Intein-based methods have been developed to facili-
tate purification and post-translational modifications ofntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Schematics of protein splicing, side reactions, trans-splicing, conditional protein splicing and expressed protein ligation. A.
Protein splicing. B. N-terminal cleavage side reaction. C. C–terminal cleavage side reaction. D. Protein trans-splicing (PTS). E. Conditional protein
splicing (CPS). The brown color of the intein box in E indicates an inactive intein, and the blue color is active. F. Expressed protein ligation (EPL).
The black box can be a protein with an N-terminal Cys, either a synthetic peptide or a protein with an N-terminal Cys revealed by proteolysis or
intein-mediated cleavage.
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and protein trans-splicing (PTS) [7-9] can produce pro-
teins with site-specific incorporation of a diverse set of
chemical modifications [6,7,10-13]. We introduce these
methods here and will describe more recent applica-
tions below.
EPL is a method to modify the C terminus of a recom-
binant protein [14,15] (Figure 1F). The protein is fused
at its C terminus to an intein, which promotes formation
of a thioester between the protein and intein. The pro-
tein is then transferred to the side chain of a synthetic
peptide with an N-terminal Cys (or a protein with N-
terminal Cys revealed by proteolysis or intein-mediated
cleavage). The peptide may contain non-native amino
acids or other chemical probes that can be incorporated
by solid phase peptide synthesis. EPL is similar to native
chemical ligation [16], which facilitates the ligation of a
small synthetic peptide with a C-terminal α-thioester to
a peptide with an N-terminal Cys. In most EPL strat-
egies, the ligated segments have no natural affinity to
each other and there is an entropic barrier to ligation.
However, this entropic barrier can be overcome if the
segments to be ligated have affinity for one another [17].In PTS, natively or artificially split inteins ligate the
exteins via a peptide bond [18,19]. The production of
semi-synthetic proteins via PTS takes advantage of the
affinity between the intein fragments. However, PTS re-
lies on efficient splicing rather than on intein side reac-
tions. Thereby it has additional challenges in that
efficient splicing may depend more heavily on the pres-
ence of short native exteins and on where the target pro-
tein is split. As a result, one may need to incorporate
short native extein sequence into the final ligation prod-
uct or substantially optimize the split site.
Intein biotechnology applications have been exten-
sively and expertly reviewed in the recent literature
[2-6]. We aim to describe in detail the most recent ad-
vances in this area, including protein expression and
modification, post-translational processing and labeling,
protein regulation by conditional protein splicing, bio-
sensors, and the expression of trans-genes.
Review
Protein expression and modification
Intein-based methods can be used to modify the se-
quence or structure of recombinant proteins, including
Figure 2 Mechanism of protein splicing. X = S or O, such that
residue 1 or the intein may be Cys or Ser, and residue C + 1 of the
C-extein may be Cys, Ser or Thr. The finishing reaction shows the
production of C-terminal Asn, but may also produce iso-Asn.
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teins with native N-terminal residues, and site-specific
proteolysis. Inteins can facilitate the expression of toxic
proteins and large proteins from within the same reading
frame, can allow for post-translational generation of small
peptides, and can serve as selectable genetic markers.Cyclization
Protein and peptide cyclization can be facilitated by
inteins by two methods (reviewed in refs [3,4,20,21].) In
the first method (Figure 3A), cyclization can be achieved
by having the protein of interest (POI) fused to different
inteins at its N and C termini [22,23]. C-terminal cleav-
age at the N-intein/target junction results in an N-
terminal Cys residue. Alternatively, an N-terminal Cys
residue may be generated by proteolysis. This Cys reacts
with an activated thioester generated at the target/C-in-
tein junction via EPL to produce cyclized protein. In the
second method (Figure 3B), split inteins are used to pro-
duce cyclized peptides or proteins. The target protein or
peptide is expressed as a fusion between C- and N-split
intein fragments [24,25]. The inversion of the placement
of the N- and C-intein fragments in the precursor(IC-protein-IN) ensures that PTS results in ligation of the
internal polypeptide fragment. The cyclization of the tar-
get proteins results in enhanced stability and bioactivity
[26-31]. One of the most exciting applications of intein-
mediated cyclization is the in vivo generation of large
libraries of genetically-encoded cyclic peptides for high
throughput screens [3]. In addition to cyclization, intein
splicing from the IC-protein-IN precursor may result in
polymerization of the target protein [32] (Figure 3C).
Proteins with uniform N-terminal residues
Inteins have been used to express proteins in E. coli with
uniform N-terminal residues [33,34]. For instance, pro-
teins expressed in their host organism that have signal
sequences often have that signal sequence cleaved by
an aminopeptidase, resulting in a protein with an N-
terminal residue other that Met. When these proteins
are over-expressed in E. coli without their native signal
sequences, they can be subject to unwanted N-terminal
processing by aminopeptidases. To avoid this cleavage
and have their native N-terminal residue, a target pro-
tein was fused at its N terminus to the Ssp DnaB mini-
intein, and expressed in an aminopeptidase-deficient
strain (Figure 3D). Upon C-terminal cleavage of the in-
tein, the target protein with the desired N-terminal
amino acid was generated [33,34].
Expression of peptides, toxic proteins, and proteins from a
single reading frame
Intein technology can be used to express challenging tar-
gets: small peptides can be expressed as part of properly
folded proteins with affinity domains, toxic proteins can
be expressed in an inactivated format, and proteins that
function in an essential stoichiometry can be expressed
from a single open reading frame.
Intein catalysis can facilitate post-translational gener-
ation of peptides by protein splicing [35] (Figure 3E).
Intein-mediated intracellular peptide production was
used to distinguish between the behavior of peptides
generated by cleavage of disordered, defective ribosomal
products and those generated from well-folded proteins.
For example, it was thought that major histocompatibil-
ity complex (MHC) class I peptides were mostly derived
from cleavage of misfolded protein fragments. However,
peptides produced via splicing of either the Mtu RecA
or Pch PRP8 mini-inteins also generated MHC class 1
epitopes. Because the intein precursor protein must be
stably folded to facilitate splicing, this suggests that
MHC peptides can be produced from stable, well-folded
proteins.
Inteins can facilitate the overexpression of toxic pro-
teins. For instance, the Sce VMA intein has been used to
create building blocks for the semi-synthesis by EPL of
active cytotoxic enzymes from inactive fragments,
Figure 3 Schematic representations of intein-mediated post-translational processing. In all panels, POI indicates protein of interest. A and
B. Intein-mediated cyclization. In A, ‘N’ indicates either an intein that generates an N-terminal Cys on the POI by C-terminal cleavage or a protein
or peptide removed by proteolysis to reveal an N-terminal Cys. C. Intein-mediated protein cyclization. D. Generation of a protein with a uniform
N-terminal residue. E. Post-translational peptide generation. F. Generation of antibodies by a single open reading frame (ORF). HC indicates heavy
chain and LC indicates light chain. G. Use of an intein as a highly specific protease. H. Selection for internal GFP labeling.
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endonuclease from Haemophilus parainfluenzae (HpaI)
[14]. Another approach is to produce non-toxic protein
precursor by inserting an intein in the toxic protein,
with activity of the target protein dependent on CPS
of the intein. For example, I-TevI endonuclease was
expressed by inserting a modified Mtu RecA intein that
is active only under specific pH conditions [36,37].
Expression of antibodies using a single open reading
frame was achieved by fusing the genes for antibody
heavy and light chains with an intein [38] (Figure 3F).
This fusion protein was successfully expressed and proc-
essed in mammalian cells, with intein-directed N- and
C- terminal cleavage reactions resulting in antibodies
with the correct sequences for both heavy and light
chains.Intein proteases
Split inteins can be used to facilitate in vivo, site-specific
protein cleavage [39] (Figure 3G). The 11-residue N-
terminal fragment of the Ssp DnaB S1 split intein was
inserted between two target sequences and used as a
cleavage site that is recognized by the C-terminal intein
fragment. This C-terminal fragment is called an intein-derived protease (IP), because on co-expression of IP
and complementation with the N-extein fragment, the
target protein is cleaved via N-terminal cleavage of the
reconstituted split intein. Site-specific protein cleavage
by the IP was demonstrated in bacterial and eukaryotic
cells. In contrast to the relatively low substrate specifi-
city of other commonly used proteases, this intein-
derived protease has very limited unintended proteolysis
of endogenous proteins resulting in minimal cellular
toxicity. The authors suggested utilization of the IP as a
molecular tool to provide control of protein cleavage in-
side living cells.Inteins as genetic markers
Inteins can facilitate in vivo gene modification by serving
as genetic markers [40] (Figure 3H). Muller and co-
workers interrupted the Pch PRP8 intein with selectable
markers, including aminoglycoside phosphotransferase
and imidazoleglycerol-phosphate dehydratase. The inter-
rupted inteins are able to splice, and could serve as se-
lectable markers for expression of the spliced extein,
GFP. This split GFP (or GFP:int) construct was used for
a single step internal labeling of calmodulin with GFP in
yeast.
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EPL and PTS have been successfully used to produce di-
verse N- and C-terminal modifications of target proteins
that are expertly reviewed in the recent literature
[7,8,10,12], including protein phosphorylation, lipidation,
glycosylation, biotinylation, ubiquitination, and segmen-
tal isotope labeling. Here we focus on in vivo protein
modifications, including protein semi-synthesis on cell
surfaces, segmental isotope labeling inside cells, and se-
lective protein labeling inside of living cells.Protein semi-synthesis on a cell surface
PTS has been used for protein semi-synthesis on a cell
surface (Figure 4A). The C terminus of the human trans-
ferrin receptor was labeled with a fluorescent group
(5-carboxy-fluorescein) on the surface of Chinese ham-
ster ovary (CHO) cells using the Ssp GyrB split intein
[41]. Likewise, the N terminus of the monomeric red
fluorescent protein (mRFP) was modified with a biotin
tag via PTS on the surface of CHO cells [42]. PTS can
be employed for ligation of an endogenous polypeptide
to a membrane protein on mammalian cells [43]. Mootz
and coworkers attached enhanced GFP (eGFP) to trans-
membrane- and GPI-anchored proteins via a PTS reac-
tion between the Npu DnaE IntC fragment fused with
the membrane-localized protein and E. coli overex-
pressed eGFP-IntN fusion.
To overcome the low binding affinity between split
intein pairs that have a short N-terminal fragment, anFigure 4 Schematic representations of intein-mediated protein labelin
represent the ligand and its receptor. In (B), ‘off’ and ‘on’ indicate condition
labeled and those in blue or red are not labeled. In (C), the conversion of tauxiliary receptor-ligand interaction was integrated, as
outlined in Figure 4A [42].
In-cell protein labeling
PTS can facilitate segmental isotopic labeling in vivo, as
well as the in vivo addition of chemical probes to spe-
cific target proteins. Cell-based PTS can provide tools
for NMR analysis [10,44] (Figure 4B). Labeled and un-
labeled precursor fragments can be produced within a
single culture. The use of a dual expression system al-
lows for sequential expression of the precursors in media
enriched with different isotopes. Incorporation of un-
labeled solubilizing tags into isotopically labeled target
proteins was demonstrated by sequential overexpression
of unlabeled domain B1 of the immunoglobulin binding
protein G (GB1) and labeled prion-inducing domain of
yeast Sup35p, each fused to Ssp DnaE split intein frag-
ments. PTS resulted in production of the protein fusion
with improved stability and solubility created by the
NMR-invisible tag [44].
Recently, several intein-based methods for selective
protein labeling inside of living cells have been devel-
oped. All of these methods employ newly developed split
inteins with very small N- or C-intein fragments, ranging
from 6 to 15 amino acids [45-49]. Because the intein
fragments are so short, they are easier to synthesize and
more likely to penetrate the cell to allow for in vivo la-
beling. Intein-based in vivo labeling has several advan-
tages over methods based on molecular recognition and
chemical modifications [50]. As opposed to directg. POI is protein of interest. In (A), the complementary pink shapes
al expression states from a plasmid, with the proteins in black 15 N
he star from clear to yellow indicates induction of fluorescence.
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intein-based recognition and minimizes the background
from non-reacted reagents.
One such intein-based labeling method uses native
chemical ligation, in both bacterial and mammalian sys-
tems, to label glutathione-S-transferase (GST) and eGFP
in vivo. The target proteins are expressed as a C-
terminal fusion to the Ssp DnaB intein, and are designed
to have an N-terminal Cys after intein C-terminal cleav-
age. The target proteins are then labeled by a cell-
permeable, thioester-containing small molecule tag such
as biotin or a fluorophore [51]. However, this ligation is
inefficient because the label and the target have no na-
tive affinity for one another, and therefore excess of one
reagent needs to be used, resulting in high background
signal. Such difficulty was overcome by Camarero and
coworkers, who utilized PTS to increase the affinity
between target protein and probe, and used a quencher
to reduce the signal from unreacted reagent [52]
(Figure 4C). The quencher was introduced to the C-
terminal Ssp or Npu DnaE intein fragment, while the
fluorophore was part of the C-extein. Therefore, the
quencher and fluorophore were part of the same mol-
ecule before splicing. On PTS, the fluorophore is ligated
to the protein of interest and dissociated from the IC-
linked quencher.
A PTS-based site-specific conjugation of a quantum
dot to the C terminus of pleckstrin homology (PH) do-
main was performed using the Ssp DnaE mini-intein in-
side of Xenopus embryos [53]. The authors speculate
that their technique allows for covalent conjugation of
any nanostructure and/or nanodevice to any protein
within the cells of the developing embryo. Later the
same group showed that the approach can be extended
to accomplish N-terminal protein tagging using the Ssp
DnaB mini-intein [54]. This work demonstrated the pos-
sibility of site-specific conjugation of quantum dots to
several proteins simultaneously, allowing for multi-
parameter imaging [54].
Regulation of protein function by conditional protein
splicing
For protein splicing to regulate the activity of a protein
in vivo, it must splice conditionally, either in cis or in
trans. CPS is activated by a trigger, such as a small mol-
ecule, light, temperature, pH or change in redox state
(reviewed in [7]). For CPS to be physiologically relevant,
it remains to be shown that native inteins are sensitive
to stimulus in their native extein contexts, expressed in
their host organism. Such evidence would counteract
the belief that inteins persist solely as selfish genetic ele-
ments, and are difficult to remove because they interrupt
key proteins such as DNA polymerase and recombinase
[55]. Rather, some inteins still may play a beneficial rolefor their host, which might provide a positive selective
pressure to retain the intein.
Small molecule induced CPS
PTS facilitated by ligand-induced dimerization domains
allows for activation of splicing by small molecules
(Figure 5A). The Sce VMA intein was split and fused to
rapamycin binding domains FKBP12 and FRB, such that
the addition of rapamycin induces intein reassociation
and PTS [56,57]. This has found in vivo applications
such as the controllable generation of firefly luciferase in
cultured cells and in Drosophila melanogaster [58], and
PTS of a tobacco etch virus protease in yeast [59]. A
mutated form of FKBP12 can be used to induce spon-
taneous reassociation and PTS of the split intein; in this
case, the addition of rapamycin prevents reassocation
and inhibits splicing [60]. Recently, Silver and coworkers
demonstrated that the FKBP12 and FRB domains could
be replaced with complementary coiled coil domains to
induce luciferase activity in mammalian cells via specific
coiled coil interactions rather than addition of a small
molecule, presumably by inducing PTS of the luciferase
segments [61].
Engineered inteins also have been created to control
cis-protein splicing (Figure 5B). The Mtu RecA intein
was interrupted by the human estrogen receptor ligand
binding domain in place of its endonuclease domain and
modified by directed evolution to splice only with the
addition of 4-hydroxytamoxifen in S. cerevisiae [62].
This was extended to mammalian cells, to facilitate spli-
cing of fluorescent reporter proteins and transcription
factors that facilitate the hedgehog pathway [63,64], and
to create a CPS-activated histone H2A variant in S. cere-
visiae [65]. The Mtu RecA intein was also interrupted by
the human thyroid hormone receptor β and shown to
control splicing of β-galactosidase and β-lactamase in E.
coli in response to thyroid hormone [66].
Therefore, it is possible to design inteins that can be
turned either on or off with a small molecule. Such
small molecule control of splicing may be used to con-
trol the active of native, non-engineered inteins. For in-
stance, cisplatin has recently been discovered to inhibit
protein splicing both in vitro and in E. coli and in M. tu-
berculosis [67] and divalent cations can prevent protein
splicing in vitro [68-73].
CPS activated by temperature, light or pH
Perrimon and coworkers developed a temperature-
sensitive version of the Sce VMA intein that allows for
timed control of protein splicing induced by temperature
changes, both in yeast and D. melanogaster [74]. The in-
tein introduces control of the activation of the transcrip-
tion factors Gal4 and Gal80, which in turn allows for
temperature-dependent activation or repression of the
Figure 5 Schematic representation of conditional protein splicing (CPS). The brown color of the boxes indicates an inactive intein, whereas
a blue intein is active. A. Conditional protein splicing triggered by protein trans-splicing. B. Conditional protein splicing triggered by protein
cis-splicing. C. Conditional protein splicing triggered by change in redox state.
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allow for more general control of protein activity by
CPS, given that control is linked to transcriptional acti-
vation, which could theoretically control any gene, rather
than linked to interrupting a specific target protein by
post-translational control. The temperature range was
recently broadened by mutagenesis [75], and was used
to control the activity of a T7 RNA polymerase in E. coli,
and hence to control the expression of lacZ under
control of the T7 promoter [76]. The temperature sensi-
tive mutant was also used to conditionally activate an
essential gene in Dictyostelium discoideum to identify
the function of the gene that is associated with a dis-
order that predisposes patients to leukemia [77]. Such
temperature-dependent CPS activity might have general
physiological relevance, as native inteins from extreme
thermophiles have been shown to be conditional on ele-
vated temperature for activity [78-85].
PTS also can be regulated by photoactivation, either
by intein fusion to a photodimerization domain [86] or
by the addition of protecting groups that are photo-cleavable [87,88], as reviewed in [7]. More recently,
Mootz and coworkers have designed a split Ssp DnaB in-
tein than can induce C-terminal cleavage on irradiation.
They used this system to liberate staphylocoagulase from
the IC segment, which in turn activated native pro-
thrombin, both in vitro and in plasma [89]. Protein spli-
cing side reactions may also be enhanced by changes in
pH [90].
CPS induced by reduction
CPS can be controlled by the redox state of a disulfide
bond that prevents an intein fusion protein from pro-
moting splicing or side reactions (Figure 5C). For in-
stance, the isolation of an unspliced precursor via
in vitro PTS can be facilitated by reassociation of split
intein fragments under oxidizing conditions, with activ-
ity induced by the addition of reducing agents [18,91].
Recently, a study in mice showed that a disulfide bond
between N- and C-extein residues improved PTS facili-
tated by the split Ssp DnaE intein, as measured by extein
activity [92]. Premature in vivo cleavage or splicing of
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duction of Cys residues in intein or extein positions in
order to use inteins in biotechnology applications [93]
or to study the mechanism of splicing [94].
Lately, there has been evidence that this disulfide-
bond control of splicing activity may have physiological
relevance. Belfort, Callahan and coworkers designed a
redox trap into the fused, cis-splicing version of the Ssp
DnaE intein, by introducing a Cys (Cys-3) residue in the
N-extein. This intein could facilitate N-terminal cleavage
only under reducing conditions in E. coli and allows for
purification of uncleaved precursor and subsequent
in vivo cleavage after addition of reducing agents [95].
This intein redox trap was subsequently used as a FRET-
based biosensor for cellular redox state, showing that
inteins can control the response of exteins by their con-
ditional activity [96]. They also discovered the MoaA in-
tein from Pyrococcus abyssi has a native disulfide bond
also between Cys-3 and Cys1 that can control intein activ-
ity [95]. The Pab PolII intein has a disulfide bond between
Cys1 and Cys + 1 that prevents splicing, and the influence
of flanking extein residues on both splicing activity and di-
sulfide bond formation appears to be linked [97]. The ac-
tivity of the Mma PolII intein is dependent on an internal
intein disulfide bond, and shows differential splicing activ-
ity based on the redox state of the E. coli strain or
localization to the periplasm or cytoplasm [98].
Intein-based biosensors
CPS permits splicing in response to a specific trigger
and lays a foundation for the development of intein-
based sensors. Most of these sensors have three func-
tionally and structurally distinct modules: a sensing
module, an output module and intein-derived signal
transducer (Figure 6A). Signal recognition by a sensor
module leads to CPS or conformational changes of the
intein connector and activation of the reporter protein.
An advantage of intein-based sensors is that the modular
design allows for easy exchange of sensor and reporter
elements, and, in cases where splicing is involved, the
presence of the intein may be trace-less after sensing.
Intein-based biosensors have been developed to detect
protein-protein interactions, changes in DNA methyla-
tion patterns, protein trafficking, small molecules, prote-
ase activity and redox state of the cell.
Sensing protein-protein interactions
Intein biosensors for protein-protein interactions utilize
PTS facilitated by split intein fragments that have low
binding affinity for each other. Design of these biosensors
involves creation of two fusion proteins, each containing
one protein binding partner, a split intein fragment and a
fragment of a reporter protein (Figure 6B). Interaction of
the binding partners facilitates split intein reconstitutionand splicing-induced complementation and activation of a
reporter protein. Umezawa and coworkers applied this
sensor design to demonstrate protein-protein interactions
in various in vivo systems ranging from E. coli to trans-
genic animals. In their original work, an E. coli-based
biosensor was developed to monitor binding between cal-
modulin and its target peptide M13, using GFP reconstitu-
tion as the reporter, mediated by the artificially split Sce
VMAI intein [99]. Next, an insulin-induced interaction be-
tween phosphorylated insulin receptor substrate 1 and its
target (the N-terminal SH2 domain of PI 3-kinase) was
observed in mammalian cells by luciferase reconstitution
by the naturally split Ssp DnaE intein [100]. Then, they
demonstrated a bioluminescence imaging method to
noninvasively and quantitatively image protein-protein
interactions in mice by intein-mediated reconstitution
of split firefly luciferase proteins driven by the inter-
action of two strongly interacting proteins, MyoD and
Id [101]. To increase the sensitivity of detection, pro-
tein splicing was employed to produce a functional
transcription factor that modulates a reporter gene,
firefly luciferase [102,103]. In this work, the epidermal
growth factor (EGF)-induced interactions of an onco-
genic product Ras and its target Raf-1 was monitored
by bioluminescence signals in mammalian cells. Not-
ably, this interaction was not detected by traditional
two-hybrid systems.
Sensing DNA methylation
Similar biosensor design was utilized in living cells for
reporting sequence specific changes in DNA methylation
via luminescence [104]. The biosensor design comprises
two fusions, each with a polydactyl zinc finger domain
fused to a split intein fragment and to a split-luciferase
domain. The luciferase reporter can be reconstituted by
conditional protein splicing upon binding of two poly-
dactyl zinc finger domains to their DNA targets. This
biosensor is capable of detecting the loss of epigenetic
silencing and increased accessibility of a DNA sequence
near the promoter region of the L1PA2 subfamily of
Line-1 retro-elements upon treatment with a demethy-
lating drug.
Sensing protein localization and internalization
Intein biosensors can be used to perform high-through-
put screens to identify protein localization in a specific
compartment. Design of these biosensors involves cre-
ation of two fusion proteins, each containing a split Ssp
DnaE intein fragment and a fragment of a reporter pro-
tein (GFP or luciferase). In addition, one of the fusion
proteins has a target protein and the other is designed to
localize in a specific compartment, such that PTS can
only occur in the appropriate cellular compartment. This
sensor design was used to study translocation of protein
Figure 6 Schematic representation of intein-mediated biosensors. Segments either colored brown or enclosed in a brown box indicate an
inactive intein or reporter. A. Overview of use of an intein as a biosensor. B. Use of an intein-based system to sense protein-protein interactions.
C. Intein-mediated allosteric biosensor for small molecule. D. Intein-mediated biosensor for protease activity. E. Intein-mediated redox biosensor.
CFP and YFP are cyan and yellow fluorescent proteins, respectively.
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lease of proteins from the mitochondria to the cytosol
[107].
In addition to the detection of protein subcellular
localization, protein splicing has been used for quantita-
tive analysis of G-protein-coupled receptor (GPCR) in-
ternalization. In this case, interaction between activated
GPCR and intracellular beta-arrestin2 results in Npu
DnaE intein-mediated reconstitution of luciferase [108].
A protein localization-dependent sensor also was de-
veloped for corticosterone detection in animals [109].
Again, the biosensor has two components. The first is a
cytosol-localized fusion of glucocorticoid receptor with
C-terminal fragments of the Ssp DnaE intein and split
luciferase. The second is a nucleus-localized fusion of
the N-terminal fragments of the intein and luciferase.
Upon corticosterone binding, the glucocorticoid recep-
tor is translocated into the nucleus, facilitating inteinfragment complementation and splicing and therefore
activation of luciferase.
Sensing small molecules
Allosteric intein biosensors can be used to detect small
molecules. Wood and coworkers have designed sensors
for ligand detection by human nuclear hormone recep-
tors utilizing allosteric effects induced by ligand-receptor
binding. The sensor does not rely on protein splicing;
the intein is used as an allosteric transmitter that allows
communication between the hormone receptor and the
reporter. The sensors exploit a four-domain fusion pro-
tein in which a nuclear receptor of interest is inserted in
a loop region of the non-splicing Mtu RecA intein. The
intein is fused to the E. coli maltose binding protein
and a T4 bacteriophage thymidylate synthase reporter
(Figure 6C). The biosensor is based on a thymidylate-
synthase deficient E. coli cell strain expressing the fusion
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late synthase reporter activity modulated by presence of
the hormone in a dose-dependent manner. Initially, the
human estrogen (ERα) and thyroid hormone (TRβ-1) re-
ceptors were used to develop highly sensitive methods
for detection of nuclear hormone receptors ligands [66].
Later, an optimized estrogen sensor was created that is
capable of identifying diverse estrogenic compounds and
differentiating between their agonistic/antagonistic
pharmacological effects [110]. Subtype-specific nuclear
hormone receptor sensors were developed for estrogen
[111] and thyroid hormone [112] receptors using the hu-
man estrogen (ERα and ERβ) and the thyroid (TRα-1
and TRβ-1) receptors as sensing domains. The peroxi-
some proliferator-activated receptor gamma (PPARγ)
ligand binding domain was used to create a series of
bacterial biosensors for the identification of functional
PPARγ ligands [113]. This study showed that the linker
region between the intein and the thymidylate synthase
reporter influences the quality of the transmission of the
allosteric signal induced by ligand binding.
A splicing-dependent allosteric intein biosensor was
employed by Liu and coworkers for construction of an
E. coli-based estrogen detector [114]. The sensing elem-
ent of this system is the estrogen-sensitive Sce VMA(ER)
intein that was generated by replacement of the endo-
nuclease region with the human estrogen receptor α.
The VMA(ER) gene was inserted in the constitutively
expressed chromosomal lacZ gene. The principal differ-
ence of this sensor from that discussed above is that the
detection here relies on estrogen-dependent intein spli-
cing and activation of the reporter protein.Sensing protease activity
A biosensor for protease activity was developed based
on in vivo intein-promoted protein cyclization [29]
(Figure 6D). Firefly luciferase was fused to a caspase-3
recognition sequence and cyclized by the inverted Ssp
DnaE split intein. In the absence of caspase activity, the
activity of the cyclized luciferase was diminished due to
steric hinderance. However, the activity of luciferase is
fully restored upon caspase-dependent cleavage, enabling
real-time quantitative sensing of caspase-3 activity in mice.Sensing oxidation state
A bacterial redox sensor was developed utilizing the
disulfide-bond control of the Ssp DnaE intein splicing
activity [96] (Figure 6E). The Ssp DnaE intein with an
engineered disulfide trap is inactive in the oxidized form
and triggered by a reducing environment to produce
N-terminal cleavage [95], as described above. This redox
sensitive intein was fused with a FRET reporter to detect
hyperoxic E. coli mutants.Delivery and control of trans-genes
Delivery and control of trans-genes in plantae
Inteins have been used to control trans-gene expression;
the initial examples were in plants and were reviewed by
Evans and coworkers in 2005 [115]. Briefly, plant genes
were first split and fused with segments of split inteins,
with extein activity demonstrated in E. coli. The advan-
tage of transferring genes that confer desired traits as
split genes is that it minimizes the chance of transfer of
the gene to unwanted hosts, such as transfer of herbicide
resistance from crops to weeds, since the weed would
need to receive both fragments of the gene separately.
For example, the split site for acetolactate synthase
(ALS) was determined by rational design, and trans-spli-
cing to produce herbicide-resistant ALS was demon-
strated in E. coli [116]. The split site for Salmonella
typhimurium 5-enolpyruvylshikimate-3-phosphate syn-
thase (EPSPS) was selected by a library-based approach
in E. coli, and the split intein segments facilitated EPSPS
activity via fragment reassociation, to create an active
split EPSPS protein, with PTS not required [117,118].
This subtlety is important to note when evaluating
claims that PTS is responsible for trans-gene activity
in vivo. Full-length EPSPS was later generated by PTS,
with expression directed to the chloroplast, in Nicotiana
tabacum [118]. This was reproduced with a more highly
herbicide resistant EPSPS from Pseudomonas fluorescens
both in E. coli and in N. tabacum [119].
A split intein was also used to generate functional,
transgenic β-glucuronidase (GUS) in Arabidopsis thali-
ana, both by PTS and by intein-mediated reassociation
of GUS fragments [120]. The split GUS-intein fusion
studies were extended to demonstrate that PTS occurs
via plasmid-induced expression in leaf cells of soybean,
pea, maize and barley [121].
Functional reconstitution of the barnase from Bacillus
amyloliquifaciens can be facilitated by the split version
of the Ssp DnaB intein [122]. The split genes were
placed under the control of a promoter for the tapetum,
such that reconstitution of the barnase results in male
sterile plants, given that the ribonuclease activity of the
barnase is toxic to the tapetum cells in the anther [123].
The split barnase can be activated by split intein seg-
ments to facilitate cytoxicity via transient agroinfiltration
of leaves from N. benthamiana or to result in male ster-
ility in transgenic A. thaliana. Rather than select for the
split barnase genes with separate genetic markers, each
fragment was genetically linked to a split gene for an
acetolactate synthase (ALS)-intein fragment fusion [19].
Therefore, expression of both the resistance gene for
sulfonylurea herbicides (ALS) and expression of the
toxic barnase require reconstitution of separate split in-
tein pairs [116]. Although PTS was not definitively
shown by a biochemical assay, the split genes did
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ile A. thaliana [123]. This work has been extended to
demonstrate PTS in transgenic Triticum aestivum
[124,125].
Intein-mediated and thermoregulated control of trans-
genic maize has been recently described with a split
xylanase, which when active breaks down plant cell walls
[126]. Building on their computational analysis of the
characteristics of intein insertion sites [127], Raab and
coworkers interrupted a thermostable xylanase from
Dictyoglomus thermophilum with the DnaE-1 intein
from Thermus thermophilus [126]. Random mutagenesis
via error-prone PCR was used to generate mutants of
the xylanase-intein fusion protein that are splicing active
only at high temperature but retain wild-type xylanase
activity. Transgenic maize expressing uninterrupted and
active xylanase produces shriveled seeds with low seed
mass, but maize expressing the xylanase-intein fusion
produces normal seeds, suggesting that toxic xylanase
activity is prevented by the intein insertion. The maize
that expresses either xylanase produces more glucose
during processing. Therefore, the thermoactive intein al-
lows for the xylanase to be expressed but not active during
maize growth, when it would be toxic, and then to be ac-
tive during bio-mass processing, when it is useful.
A split DnaB intein was used to facilitate polymeriza-
tion of spider silk flagelliform protein in tobacco plant
leaves by both stable and transient transfection [32]
(Figure 3C).
Trans-genes in other organisms
Recently, PTS in mammalian cells and in mice has been
used to test delivery of trans-genes by adenovirus deliv-
ery vectors. The split fragments of the Ssp DnaE intein
were fused to heavy and light chain genes for the
B-domain deleted factor VIII, and delivered to mamma-
lian cells or mice by separate viral vectors [92,128].
Splicing activity is suggested by increased coagulation
activity and the concentrations of functional protein in
the plasma, suggesting that PTS could be used for the
in vivo generation of proteins too large to be delivered
by traditional viral vectors. The split Ssp DnaE intein also
was used to facilitate split Cre reconstitution in mice. In
short, fragments of split Cre recombinase can be fused to
separate promoters that drive expression under different
conditions. Under conditions where both Cre fragments
are expressed, Cre is reconstituted and facilitates expres-
sion of genes under control of the Cre-LoxP system. The
Ssp DnaE intein was shown to help improve functional
Cre fragment complementation [129].
Conclusions
It is exciting to observe that biotechnology applications
of protein splicing have begun to move from proof-of-concept experiments to productive applications in which
the intein is the tool rather than the object of study it-
self. However, the variability in how inteins behave in
heterologous contexts can be a limiting factor in the gen-
eral applicability of intein-based biotechnology. Going for-
ward, recent advances in the understanding of the role of
flanking extein residues in the splicing process [130-136]
may improve our ability to predict or ameliorate this chal-
lenge. The discovery of split inteins that splice even faster
than the Npu DnaE intein [137] also may increase the effi-
ciency of PTS-based applications. The growing number of
examples of in vivo protein manipulation using intein ca-
talysis also promises advancement in intein-based tools
for systems and functional biology.
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